Quantum BioPharma Ltd. (CSE:QNTM)
Canada · Delayed Price · Currency is CAD 5.00
+0.25 (5.26%)
Jul 6, 2026, 11:24 AM EST
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of CAD 30.39 million as of July 6, 2026. Its market cap has decreased by -62.33% in one year.
Market Cap
30.39M
Enterprise Value
22.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.00
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from 158.35M to 30.39M, a decrease of -80.81%. That is a compound annual growth rate of -18.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 30.39M | -24.51% |
| Dec 31, 2025 | 40.26M | 301.84% |
| Dec 31, 2024 | 10.02M | -78.79% |
| Dec 29, 2023 | 47.25M | 18.00% |
| Dec 30, 2022 | 40.04M | -24.98% |
| Dec 31, 2021 | 53.38M | 39.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 41.33M |
| BriaCell Therapeutics | 39.58M |
| Medicenna Therapeutics | 36.46M |
| Defence Therapeutics | 32.97M |
| Sona Nanotech | 32.03M |
| Resverlogix | 30.95M |
| Thiogenesis Therapeutics | 29.55M |
| Alzai Health | 28.87M |